Trump's Prescription for Higher Prices: A Misguided Executive Order

Strategic Insights -

Donald Trump's latest executive order aims to reduce prescription drug prices in the US, but experts say it will not accomplish much. The order directs the HHS Secretary to come up with a plan to determine "most-favored-nation price targets" for pharmaceutical companies, but this is a hollow promise since presidents do not have the power to dictate prices to private companies.

The order is framed as a response to Big Pharma taking advantage of Americans by negotiating lower prices for their drugs, but in reality, the US has a complex healthcare system that leaves negotiations up to private insurers. Trump's solution is to threaten regulatory action, but this has no basis in law, as courts have already put similar orders on hold.

The executive order also instructs federal agencies to find out why European countries get away with paying less for prescription drugs, but American presidents are not the boss of other countries' healthcare. Drug companies are already locked into contracts with governments, and higher prices in Europe would not necessarily lead to lower prices in the US.

Experts say that Trump's order will not reduce prescription drug prices in the near future. Instead, it includes a pretty good point about Big Pharma relying on publicly funded medical research to develop many of their products, making huge profits from selling them in the US while justifying high costs due to the need for innovation. However, Trump's "solution" is flawed, as it consists of asking for lower prices and threatening regulatory action without any basis in law.

Key Takeaways:

  • The executive order directs the HHS Secretary to come up with a plan to determine "most-favored-nation price targets" for pharmaceutical companies.
  • This is a hollow promise since presidents do not have the power to dictate prices to private companies.
  • The order is framed as a response to Big Pharma taking advantage of Americans by negotiating lower prices for their drugs.
  • However, the real issue is the complex US healthcare system that leaves negotiations up to private insurers.
  • Trump's solution is to threaten regulatory action, but this has no basis in law, as courts have already put similar orders on hold.
  • The executive order also instructs federal agencies to find out why European countries get away with paying less for prescription drugs.
  • American presidents are not the boss of other countries' healthcare.
  • Higher prices in Europe would not necessarily lead to lower prices in the US.
  • Experts say that Trump's order will not reduce prescription drug prices in the near future.
  • Instead, it highlights the flawed nature of the US healthcare system, where companies rely on publicly funded research but make huge profits from selling expensive drugs.
  • Universal healthcare, proposed by Democrats, is the real solution to reduce prescription drug prices, but Trump is unwilling to consider this option.

Statistics:

  • 30% to 80% reduction in prescription drug prices, as claimed by Trump.
  • 2022: The year Joe Biden's Inflation Reduction Act was passed, which included a $35 per month insulin price cap and a plan to negotiate prescription drug costs for Medicare.
  • 2025: The year Trump's executive order was issued.
  • 1 in 5 Americans struggle to afford prescription medication (Source: Kaiser Family Foundation).
  • Prescription drug prices have increased by 130% since 2010 (Source: CNN).

Sources:

  • [1] AP News: "Trump orders Big Pharma to reduce prescription drug prices"
  • [2] The New York Times: "Trump orders pharmaceutical companies to reduce prices of prescription drugs"
  • [3] Wonkette: "Trump Orders Big Pharma To Reduce Prices, Because That's Exactly How Commands Work"
  • [4] AP News: "Trump orders Big Pharma to reduce prescription drug prices, but experts say it won't work"
  • [5] The New York Times: "Trump's Prescription Drug Plan Won't Help, Experts Say"